Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Intracellular protein trafficking
- Protein maturation in the secretory pathway
- How proteins first encounter the secretory pathway
- Processes in the ER
- Protein modifications (1)
- Protein modifications (2)
- Alteration of residues
- ER glycoforms
- The glyco-code of the ER
- Calnexin and calreticulin (1)
- Crystal structure of calnexin
- Calnexin and calreticulin binding to HA
- Calnexin binding cycle (1)
- Calnexin/calreticulin functions
- Co-translational folding
- Average protein synthesis time
- Influenza hemagglutinin
- Oxidation of HA
- HA truncations
- A model for HA maturation
- Type I membrane proteins
- Proteins protecting the nascent chain
- Qaulity control
- Loss of function vs. gain of toxicity
- Diseses involving ER folding and quality control
- Tyrosinase is a bona fide ERAD substrate
- Tyr(C85S) is retained in the ER
- Functional vs. structural
- Structural determinants that cause retention
- ER retention signals
- Calnexin binding cycle (2)
- GT, or UDP-glucose glycoprotein
- Degradation of misfolded proteins
- Importance of carbohydrate trimming
- EDEM1, a putative mannose-binding protein
- EDEM1 and degradation of ERAD substrates
- EDEM1 extracts proteins from the calnexin cycle
- Summary-maturation and qaulity control in the ER
Topics Covered
- Protein maturation in the secretory pathway
- ER glycoforms
- The glyco-code of the ER
- Calnexin and calreticulin
- Cotranslational folding
- Influenza hemagglutinin
- Oxidation of HA
- HA truncations
- Type I membrane proteins
- Disease states involving ER folding and quality control
- Structural determinants that cause retention
- ER retention signals
- Calnexin binding cycle
- GT or UDP glucose glycoprotein: glycosyltransferase
- Degradation of misfolded proteins
- Carbohydrate trimming
- EDEM1 functions
Talk Citation
Hebert, D. (2007, October 1). Glycoprotein maturation and quality control in the endoplasmic reticulum [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/KAXE9724.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Daniel Hebert has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Hide